John Sfakianos
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer (NCT06503614) | John Sfakianos | 2025-02-24 |
Track John Sfakianos automatically
Every clearance here is in the API, with alerts when new ones post.